Follow the people · Insider
Milton C. Ault III
Milton C. Ault III files insider transactions with the SEC as a vice chairman of Universal Security Instruments (UUU). We hold 72 disclosed purchases and sales filed since 4 January 2006, 31 of them in the last 90 days.
- Files forUUU
- Disclosed buys and sells72 in all, 31 in the last 90 days
- Last disclosure8 September 2026
Positions held
20 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 30 May 2025 — 4 September 2026Vice Chairman · Universal Security Instruments (UUU)148 Form 4 lines · source: SEC Form 4
- Filed 28 June 2023 — 4 September 2026Executive Chairman · Hyperscale Data (GPUS)102 Form 4 lines · source: SEC Form 4
- Filed 15 June 2021 — 26 August 2026Director · Alzamend Neuro (ALZN)224 Form 4 lines · source: SEC Form 4
- Filed 9 September 2024 — 7 October 2024Other role · Algorhythm Holdings (RIME)22 Form 4 lines · source: SEC Form 4
- Filed 23 February 2021 — 30 September 2024Director and 10% owner · Ault Disruptive Technologies (ADRT)10 Form 4 lines · source: SEC Form 4
- Filed 9 January 2023 — 11 September 2024Executive Chairman · Ault Alliance (AULT)60 Form 4 lines · source: SEC Form 4
- Filed 23 January 2024 — 24 April 2024Chief Executive Officer · RiskOn International (ROII)4 Form 4 lines · source: SEC Form 4
- Filed 15 November 2023 — 29 February 2024Chief Executive Officer · RiskOn International (ROI)13 Form 4 lines · source: SEC Form 4
- Filed 23 August 2023 — 26 September 202310% owner · BitNile Metaverse (BNMV)13 Form 4 lines · source: SEC Form 4
- Filed 9 February 2023 — 23 May 2023Executive Chairman · Singing Machine Co (MICS)3 Form 4 lines · source: SEC Form 4
- Filed 31 December 2021 — 29 December 2022Executive Chairman · BitNile Holdings (NILE)106 Form 4 lines · source: SEC Form 4
- Filed 25 August 2017 — 9 December 2021Executive Chairman · DPW Holdings (DPW)104 Form 4 lines · source: SEC Form 4
- Filed 28 June 2021 — 28 June 202110% owner · SilverSun Technologies (SSNT)1 Form 4 line · source: SEC Form 4
- Filed 11 March 2009 — 13 April 2009CEO · Zealous (ZLUS)4 Form 4 lines · source: SEC Form 4
- Filed 23 January 2009 — 30 January 2009Chief Executive Officer · Zealous (ADLE)10 Form 4 lines · source: SEC Form 4
- Filed 15 November 2007 — 8 September 2008Chief Executive Officer · Zealous Trading Group (ZLST.OB)6 Form 4 lines · source: SEC Form 4
- Filed 21 August 2007 — 31 August 2007CEO · Atlantic Syndication Network (ASNI)4 Form 4 lines · source: SEC Form 4
- Filed 3 November 2004 — 7 March 200710% owner · Patient Safety Technologies (PSTX.OB)6 Form 4 lines · source: SEC Form 4
- Filed 3 November 2004 — 7 March 2007CEO · Patient Safety Technologies (PST)26 Form 4 lines · source: SEC Form 4
- Filed 30 December 2005 — 27 June 2006Director · Ipex (IPEX)8 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- was granted 50,000 shares of Universal Safety Products (a derivative holding)SEC Form 422 October 2025Stock Options (Right to Buy) · traded 20 October 2025 · filed 22 October 2025
- was granted 350 shares of Hyperscale Data (a derivative holding)SEC Form 420 June 2025Series C Convertible Preferred Stock · traded 4 October 2024 · filed 20 June 2025
- was granted 2,956 shares of Hyperscale Data (a derivative holding)SEC Form 420 June 2025Series C Warrants · traded 4 October 2024 · filed 20 June 2025
- was granted 500 shares of Hyperscale Data (a derivative holding)SEC Form 420 June 2025Series C Convertible Preferred Stock · traded 10 October 2024 · filed 20 June 2025
- was granted 4,223 shares of Hyperscale Data (a derivative holding)SEC Form 420 June 2025Series C Warrants · traded 10 October 2024 · filed 20 June 2025
- was granted 450 shares of Hyperscale Data (a derivative holding)SEC Form 420 June 2025Series C Convertible Preferred Stock · traded 18 October 2024 · filed 20 June 2025
- was granted 3,801 shares of Hyperscale Data (a derivative holding)SEC Form 420 June 2025Series C Warrants · traded 18 October 2024 · filed 20 June 2025
- was granted 100 shares of Hyperscale Data (a derivative holding)SEC Form 420 June 2025Series C Convertible Preferred Stock · traded 22 October 2024 · filed 20 June 2025
- was granted 845 shares of Hyperscale Data (a derivative holding)SEC Form 420 June 2025Series C Warrants · traded 22 October 2024 · filed 20 June 2025
- was granted 95 shares of Hyperscale Data (a derivative holding)SEC Form 420 June 2025Series C Convertible Preferred Stock · traded 13 November 2024 · filed 20 June 2025
- was granted 802 shares of Hyperscale Data (a derivative holding)SEC Form 420 June 2025Series C Warrants · traded 13 November 2024 · filed 20 June 2025
- was granted 735 shares of Hyperscale Data (a derivative holding)SEC Form 420 June 2025Series C Convertible Preferred Stock · traded 15 November 2024 · filed 20 June 2025
- was granted 6,208 shares of Hyperscale Data (a derivative holding)SEC Form 420 June 2025Series C Warrants · traded 15 November 2024 · filed 20 June 2025
- was granted 400 shares of Hyperscale Data (a derivative holding)SEC Form 420 June 2025Series C Convertible Preferred Stock · traded 19 November 2024 · filed 20 June 2025
- was granted 3,379 shares of Hyperscale Data (a derivative holding)SEC Form 420 June 2025Series C Warrants · traded 19 November 2024 · filed 20 June 2025
- was granted 50 shares of Hyperscale Data (a derivative holding)SEC Form 420 June 2025Series C Convertible Preferred Stock · traded 21 November 2024 · filed 20 June 2025
- was granted 422 shares of Hyperscale Data (a derivative holding)SEC Form 420 June 2025Series C Warrants · traded 21 November 2024 · filed 20 June 2025
- was granted 570 shares of Hyperscale Data (a derivative holding)SEC Form 420 June 2025Series C Convertible Preferred Stock · traded 4 December 2024 · filed 20 June 2025
- was granted 4,815 shares of Hyperscale Data (a derivative holding)SEC Form 420 June 2025Series C Warrants · traded 4 December 2024 · filed 20 June 2025
- was granted 50 shares of Hyperscale Data (a derivative holding)SEC Form 420 June 2025Series C Convertible Preferred Stock · traded 10 December 2024 · filed 20 June 2025
- was granted 422 shares of Hyperscale Data (a derivative holding)SEC Form 420 June 2025Series C Warrants · traded 10 December 2024 · filed 20 June 2025
- was granted 500 shares of Hyperscale Data (a derivative holding)SEC Form 420 June 2025Series C Convertible Preferred Stock · traded 12 December 2024 · filed 20 June 2025
- was granted 4,223 shares of Hyperscale Data (a derivative holding)SEC Form 420 June 2025Series C Warrants · traded 12 December 2024 · filed 20 June 2025
- was granted 4,234,561 shares of Hyperscale Data (a derivative holding)SEC Form 420 June 2025Class B Common Stock · traded 16 December 2024 · filed 20 June 2025
- was granted 1,900 shares of Hyperscale Data (a derivative holding)SEC Form 420 June 2025Series C Convertible Preferred Stock · traded 20 December 2024 · filed 20 June 2025
- was granted 16,049 shares of Hyperscale Data (a derivative holding)SEC Form 420 June 2025Series C Warrants · traded 20 December 2024 · filed 20 June 2025
- was granted 495 shares of Hyperscale Data (a derivative holding)SEC Form 420 June 2025Series G Convertible Preferred Stock · traded 3 January 2025 · filed 20 June 2025
- was granted 83,643 shares of Hyperscale Data (a derivative holding)SEC Form 420 June 2025Series G Warrants · traded 3 January 2025 · filed 20 June 2025
- was granted 365 shares of Hyperscale Data (a derivative holding)SEC Form 420 June 2025Series G Convertible Preferred Stock · traded 6 January 2025 · filed 20 June 2025
- was granted 61,676 shares of Hyperscale Data (a derivative holding)SEC Form 420 June 2025Series G Warrants · traded 6 January 2025 · filed 20 June 2025
- was granted 100 shares of Hyperscale Data (a derivative holding)SEC Form 420 June 2025Series G Convertible Preferred Stock · traded 10 April 2025 · filed 20 June 2025
- was granted 16,898 shares of Hyperscale Data (a derivative holding)SEC Form 420 June 2025Series G Warrants · traded 10 April 2025 · filed 20 June 2025
- ▲ bought on the open market 2,300 shares of Alzamend NeuroSEC Form 425 July 2022Common Stock · traded 22 July 2022 · filed 25 July 2022
- ▲ bought on the open market 135,000 shares of BitNile HoldingsSEC Form 422 July 2022Common Stock · traded 21 July 2022 · filed 22 July 2022
- ▲ bought on the open market 130,000 shares of BitNile HoldingsSEC Form 421 July 2022Common Stock · traded 20 July 2022 · filed 21 July 2022
- ▲ bought on the open market 140,000 shares of BitNile HoldingsSEC Form 420 July 2022Common Stock · traded 19 July 2022 · filed 20 July 2022
- ▲ bought on the open market 2,000 shares of BitNile HoldingsSEC Form 420 July 202213% Series D Cumulative Redeemable Perpetual Preferred Stock · traded 19 July 2022 · filed 20 July 2022
- ▲ bought on the open market 10,000 shares of Alzamend NeuroSEC Form 419 July 2022Common Stock · traded 18 July 2022 · filed 19 July 2022
- ▲ bought on the open market 150,000 shares of BitNile HoldingsSEC Form 418 July 2022Common Stock · traded 15 July 2022 · filed 18 July 2022
- ▲ bought on the open market 320,000 shares of BitNile HoldingsSEC Form 415 July 2022Common Stock · traded 14 July 2022 · filed 15 July 2022
- ▲ bought on the open market 435,229 shares of BitNile HoldingsSEC Form 414 July 2022Common Stock · traded 13 July 2022 · filed 14 July 2022
- ▲ bought on the open market 834,686 shares of BitNile HoldingsSEC Form 413 July 2022Common Stock · traded 12 July 2022 · filed 13 July 2022
- ▲ bought on the open market 918,211 shares of BitNile HoldingsSEC Form 411 July 2022Common Stock · traded 7 July 2022 · filed 11 July 2022
- ▲ bought on the open market 300,000 shares of BitNile HoldingsSEC Form 411 July 2022Common Stock · traded 8 July 2022 · filed 11 July 2022
- ▲ bought on the open market 908,032 shares of BitNile HoldingsSEC Form 47 July 2022Common Stock · traded 6 July 2022 · filed 7 July 2022
- ▲ bought on the open market 1,249,678 shares of BitNile HoldingsSEC Form 46 July 2022Common Stock · traded 5 July 2022 · filed 6 July 2022
- ▲ bought on the open market 1,129,164 shares of BitNile HoldingsSEC Form 45 July 2022Common Stock · traded 1 July 2022 · filed 5 July 2022
- ▲ bought on the open market 900,000 shares of BitNile HoldingsSEC Form 41 July 2022Common Stock · traded 30 June 2022 · filed 1 July 2022
- ▲ bought on the open market 900,000 shares of BitNile HoldingsSEC Form 430 June 2022Common Stock · traded 29 June 2022 · filed 30 June 2022
- ▲ bought on the open market 10,000 shares of Alzamend NeuroSEC Form 430 June 2022Common Stock · traded 29 June 2022 · filed 30 June 2022
- ▲ bought on the open market 100,000 shares of BitNile HoldingsSEC Form 424 June 2022Common Stock · traded 22 June 2022 · filed 24 June 2022
- ▲ bought on the open market 125,000 shares of BitNile HoldingsSEC Form 424 June 2022Common Stock · traded 23 June 2022 · filed 24 June 2022
- ▲ bought on the open market 10,000 shares of Alzamend NeuroSEC Form 421 June 2022Common Stock · traded 17 June 2022 · filed 21 June 2022
- ▲ bought on the open market 10,000 shares of Alzamend NeuroSEC Form 416 June 2022Common Stock · traded 15 June 2022 · filed 16 June 2022
- ▲ bought on the open market 10,000 shares of Alzamend NeuroSEC Form 415 June 2022Common Stock · traded 14 June 2022 · filed 15 June 2022
- ▲ bought on the open market 917,957 shares of BitNile HoldingsSEC Form 415 June 2022Common Stock · traded 14 June 2022 · filed 15 June 2022
- ▲ bought on the open market 82,043 shares of BitNile HoldingsSEC Form 415 June 2022Common Stock · traded 15 June 2022 · filed 15 June 2022
- ▲ bought on the open market 1,000,000 shares of BitNile HoldingsSEC Form 414 June 2022Common Stock · traded 13 June 2022 · filed 14 June 2022
- ▲ bought on the open market 500 shares of BitNile HoldingsSEC Form 414 June 202213% Series D Cumulative Redeemable Perpetual Preferred Stock · traded 10 June 2022 · filed 14 June 2022
- ▲ bought on the open market 1,200 shares of BitNile HoldingsSEC Form 410 June 202213% Series D Cumulative Redeemable Perpetual Preferred Stock · traded 9 June 2022 · filed 10 June 2022
- ▲ bought on the open market 500 shares of BitNile HoldingsSEC Form 410 June 202213% Series D Cumulative Redeemable Perpetual Preferred Stock · traded 9 June 2022 · filed 10 June 2022
- ▲ bought on the open market 7,000 shares of BitNile HoldingsSEC Form 49 June 202213% Series D Cumulative Redeemable Perpetual Preferred Stock · traded 7 June 2022 · filed 9 June 2022
- ▲ bought on the open market 1,000 shares of BitNile HoldingsSEC Form 49 June 202213% Series D Cumulative Redeemable Perpetual Preferred Stock · traded 8 June 2022 · filed 9 June 2022
- ▲ bought on the open market 256 shares of BitNile HoldingsSEC Form 49 June 202213% Series D Cumulative Redeemable Perpetual Preferred Stock · traded 8 June 2022 · filed 9 June 2022
- ▲ bought on the open market 8,000 shares of Alzamend NeuroSEC Form 49 June 2022Common Stock · traded 8 June 2022 · filed 9 June 2022
- ▲ bought on the open market 2,000 shares of Alzamend NeuroSEC Form 48 June 2022Common Stock · traded 7 June 2022 · filed 8 June 2022
- ▲ bought on the open market 8,000 shares of Alzamend NeuroSEC Form 43 June 2022Common Stock · traded 2 June 2022 · filed 3 June 2022
- ▲ bought on the open market 42,577 shares of BitNile HoldingsSEC Form 43 June 202213% Series D Cumulative Redeemable Perpetual Preferred Stock · traded 3 June 2022 · filed 3 June 2022
- ▲ bought on the open market 1,429,605 shares of BitNile HoldingsSEC Form 42 June 2022Common Stock · traded 31 May 2022 · filed 2 June 2022
- ▲ bought on the open market 2,470,395 shares of BitNile HoldingsSEC Form 42 June 2022Common Stock · traded 1 June 2022 · filed 2 June 2022
- ▲ bought on the open market 7,500 shares of BitNile HoldingsSEC Form 42 June 2022Common Stock · traded 1 June 2022 · filed 2 June 2022
- ▲ bought on the open market 10,000 shares of Alzamend NeuroSEC Form 431 May 2022Common Stock · traded 26 May 2022 · filed 31 May 2022
- ▲ bought on the open market 12,000 shares of Alzamend NeuroSEC Form 431 May 2022Common Stock · traded 27 May 2022 · filed 31 May 2022
- ▲ bought on the open market 1,300,000 shares of BitNile HoldingsSEC Form 431 May 2022Common Stock · traded 26 May 2022 · filed 31 May 2022
- ▲ bought on the open market 2,700,000 shares of BitNile HoldingsSEC Form 431 May 2022Common Stock · traded 27 May 2022 · filed 31 May 2022
- ▲ bought on the open market 16,100 shares of Alzamend NeuroSEC Form 426 May 2022Common Stock · traded 24 May 2022 · filed 26 May 2022
- ▲ bought on the open market 3,000,000 shares of BitNile HoldingsSEC Form 426 May 2022Common Stock · traded 24 May 2022 · filed 26 May 2022
- ▲ bought on the open market 40,000 shares of BitNile HoldingsSEC Form 426 May 2022Common Stock · traded 24 May 2022 · filed 26 May 2022
- ▲ bought on the open market 2,000,000 shares of BitNile HoldingsSEC Form 426 May 2022Common Stock · traded 25 May 2022 · filed 26 May 2022
- ▲ bought on the open market 2,500 shares of BitNile HoldingsSEC Form 426 May 2022Common Stock · traded 25 May 2022 · filed 26 May 2022
- acquired or disposed of, other 39 shares of Alzamend Neuro (a derivative holding)SEC Form 424 May 2022Put Option (obligation to buy) · traded 20 May 2022 · filed 24 May 2022
- acquired or disposed of, other 3,900 shares of Alzamend NeuroSEC Form 424 May 2022Common Stock · traded 20 May 2022 · filed 24 May 2022
- acquired or disposed of, other 11 shares of Alzamend Neuro (a derivative holding)SEC Form 418 May 2022Put Option (obligation to buy) · traded 17 May 2022 · filed 18 May 2022
- ▲ bought on the open market 23,900 shares of Alzamend NeuroSEC Form 418 May 2022Common Stock · traded 17 May 2022 · filed 18 May 2022
- acquired or disposed of, other 1,100 shares of Alzamend NeuroSEC Form 418 May 2022Common Stock · traded 17 May 2022 · filed 18 May 2022
- exercised options over 66,667 shares of BitNile Holdings (a derivative holding)SEC Form 417 May 2022Restricted Stock Grant · traded 15 May 2022 · filed 17 May 2022
- exercised options over 66,667 shares of BitNile HoldingsSEC Form 417 May 2022Common Stock · traded 15 May 2022 · filed 17 May 2022
- ▲ bought on the open market 100,000 shares of Alzamend NeuroSEC Form 413 May 2022Common Stock · traded 6 May 2022 · filed 13 May 2022
- ▲ bought on the open market 25,000 shares of Alzamend NeuroSEC Form 413 May 2022Common Stock · traded 12 May 2022 · filed 13 May 2022
- ▲ bought on the open market 100,000 shares of Alzamend NeuroSEC Form 46 May 2022Common Stock · traded 5 May 2022 · filed 6 May 2022
- acquired or disposed of, other 1,333,333 shares of Alzamend Neuro (a derivative holding)SEC Form 428 April 2022Warrants · traded 26 April 2022 · filed 28 April 2022
- ▲ bought on the open market 2,666,667 shares of Alzamend NeuroSEC Form 428 April 2022Common Stock · traded 26 April 2022 · filed 28 April 2022
- ▲ bought on the open market 75,000 shares of Alzamend NeuroSEC Form 425 April 2022Common Stock · traded 22 April 2022 · filed 25 April 2022
- ▲ bought on the open market 50,000 shares of Alzamend NeuroSEC Form 412 April 2022Common Stock · traded 11 April 2022 · filed 12 April 2022
- ▲ bought on the open market 100,000 shares of Alzamend NeuroSEC Form 421 March 2022Common Stock · traded 18 March 2022 · filed 21 March 2022
- acquired or disposed of, other 57,016 shares of Alzamend NeuroSEC Form 48 March 2022Common Stock · traded 4 March 2022 · filed 8 March 2022
- ▲ bought on the open market 95,959 shares of BitNile HoldingsSEC Form 44 March 2022Common Stock · traded 4 March 2022 · filed 4 March 2022
- ▲ bought on the open market 60,000 shares of BitNile HoldingsSEC Form 43 March 2022Common Stock · traded 2 March 2022 · filed 3 March 2022
- ▲ bought on the open market 57,571 shares of BitNile HoldingsSEC Form 43 March 2022Common Stock · traded 3 March 2022 · filed 3 March 2022
- ▲ bought on the open market 39,069 shares of BitNile HoldingsSEC Form 41 March 2022Common Stock · traded 1 March 2022 · filed 1 March 2022
- ▲ bought on the open market 22,500 shares of Alzamend NeuroSEC Form 425 February 2022Common Stock · traded 24 February 2022 · filed 25 February 2022
- ▲ bought on the open market 47,901 shares of BitNile HoldingsSEC Form 424 February 2022Common Stock · traded 24 February 2022 · filed 24 February 2022
- ▲ bought on the open market 20,000 shares of BitNile HoldingsSEC Form 411 February 2022Common Stock · traded 10 February 2022 · filed 11 February 2022
- ▲ bought on the open market 7,100,000 shares of Ault Disruptive Technologies (a derivative holding)SEC Form 411 February 2022Warrants · traded 15 December 2021 · filed 11 February 2022
- ▲ bought on the open market 750 shares of Ault Disruptive Technologies (a derivative holding)SEC Form 411 February 2022Warrants · traded 16 December 2021 · filed 11 February 2022
- ▲ bought on the open market 150 shares of Ault Disruptive Technologies (a derivative holding)SEC Form 411 February 2022Warrants · traded 21 December 2021 · filed 11 February 2022
- ▲ bought on the open market 2,875,000 shares of Ault Disruptive TechnologiesSEC Form 411 February 2022Common Stock · traded 23 February 2021 · filed 11 February 2022
- ▲ bought on the open market 1,000 shares of Ault Disruptive TechnologiesSEC Form 411 February 2022Common Stock · traded 16 December 2021 · filed 11 February 2022
- ▲ bought on the open market 200 shares of Ault Disruptive TechnologiesSEC Form 411 February 2022Common Stock · traded 21 December 2021 · filed 11 February 2022
- ▲ bought on the open market 25,000 shares of BitNile HoldingsSEC Form 410 February 2022Common Stock · traded 9 February 2022 · filed 10 February 2022
- ▲ bought on the open market 37,500 shares of BitNile HoldingsSEC Form 49 February 2022Common Stock · traded 8 February 2022 · filed 9 February 2022
- ▲ bought on the open market 45,000 shares of BitNile HoldingsSEC Form 48 February 2022Common Stock · traded 7 February 2022 · filed 8 February 2022
- ▲ bought on the open market 25,000 shares of BitNile HoldingsSEC Form 47 February 2022Common Stock · traded 4 February 2022 · filed 7 February 2022
- ▲ bought on the open market 10,000 shares of BitNile HoldingsSEC Form 44 February 2022Common Stock · traded 3 February 2022 · filed 4 February 2022
- ▲ bought on the open market 40,000 shares of BitNile HoldingsSEC Form 42 February 2022Common Stock · traded 2 February 2022 · filed 2 February 2022
- exercised options over 2,250,000 shares of Alzamend Neuro (a derivative holding)SEC Form 41 February 2022Stock Options (Right to Buy) · traded 1 February 2022 · filed 1 February 2022
- exercised options over 2,250,000 shares of Alzamend NeuroSEC Form 41 February 2022Common Stock · traded 1 February 2022 · filed 1 February 2022
- ▲ bought on the open market 7,000 shares of BitNile HoldingsSEC Form 41 February 2022Common Stock · traded 28 January 2022 · filed 1 February 2022
- ▲ bought on the open market 15,000 shares of BitNile HoldingsSEC Form 41 February 2022Common Stock · traded 1 February 2022 · filed 1 February 2022
- ▲ bought on the open market 2,500 shares of Alzamend NeuroSEC Form 428 January 2022Common Stock · traded 27 January 2022 · filed 28 January 2022
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.